We are live on ! Find out more
LD

Lipe & Dalton Portfolio holdings

AUM $215M
1-Year Est. Return 39.53%
This Fund
S&P 500
This Quarter Est. Return
-18.39%
1 Year Est. Return
+39.53%
3 Year Est. Return
+89.64%
5 Year Est. Return
+111.74%
10 Year Est. Return
+427.59%
AUM
$118M
AUM Growth
-$32.6M
Cap. Flow
-$569K
Cap. Flow %
-0.48%
Top 10 Hldgs %
37.61%
Holding
108
New
3
Increased
17
Reduced
43
Closed
11

Top Buys

Rank Stock Value
1
LDOS icon
Leidos
LDOS
+$3.05M
2
MCK icon
McKesson
MCK
+$2.65M
3
BCE icon
BCE
BCE
+$1.48M
4
BKNG icon
Booking.com
BKNG
+$574K
5
EXAS
Exact Sciences
EXAS
+$525K

Top Sells

Rank Stock Value
1
HSY icon
Hershey
HSY
+$1.98M
2
MDLZ icon
Mondelez International
MDLZ
+$992K
3
AAPL icon
Apple
AAPL
+$899K
4
LEA icon
Lear
LEA
+$659K
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$478K

Sector Composition

Rank Sector Weight
1 Healthcare 27.67%
2 Technology 20.14%
3 Financials 14.32%
4 Industrials 12.43%
5 Communication Services 10.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.89T
$7.71M 6.52%
121,292
-12,224
-9% -$899K
INTC icon
2
Intel
INTC
$466B
$5.89M 4.98%
108,777
-3,587
-3% -$212K
GOOG icon
3
Alphabet (Google) Class C
GOOG
$3.9T
$4.43M 3.75%
76,260
-1,840
-2% -$125K
BN icon
4
Brookfield
BN
$102B
$4.28M 3.62%
270,876
-5,908
-2% -$122K
BMY icon
5
Bristol-Myers Squibb
BMY
$127B
$4.07M 3.44%
73,040
-1,404
-2% -$85.8K
TRP icon
6
TC Energy
TRP
$73.5B
$3.72M 3.15%
84,013
-1,813
-2% -$91.9K
BIIB icon
7
Biogen
BIIB
$29.9B
$3.66M 3.1%
11,575
-245
-2% -$74.4K
DHR icon
8
Danaher
DHR
$135B
$3.61M 3.05%
29,393
-1,174
-4% -$158K
GILD icon
9
Gilead Sciences
GILD
$161B
$3.55M 3%
47,485
-4,650
-9% -$321K
BAX icon
10
Baxter International
BAX
$11.6B
$3.54M 3%
43,635
-1,349
-3% -$116K
RTX icon
11
RTX Corp
RTX
$287B
$3.52M 2.98%
59,251
-1,380
-2% -$117K
BCE icon
12
BCE
BCE
$19.9B
$3.5M 2.96%
85,732
+32,947
+62% +$1.48M
CVS icon
13
CVS Health
CVS
$137B
$3.48M 2.94%
58,648
-937
-2% -$62.6K
GS icon
14
Goldman Sachs
GS
$313B
$3.29M 2.78%
21,271
-266
-1% -$56.5K
MCK icon
15
McKesson
MCK
$98.5B
$3.25M 2.75%
24,020
+18,065
+303% +$2.65M
TEL icon
16
TE Connectivity
TEL
$58.8B
$3.13M 2.64%
49,613
-990
-2% -$84.5K
ABBV icon
17
AbbVie
ABBV
$458B
$2.99M 2.53%
39,299
+2,506
+7% +$213K
CM icon
18
Canadian Imperial Bank of Commerce
CM
$107B
$2.88M 2.44%
99,490
-1,970
-2% -$73.3K
LDOS icon
19
Leidos
LDOS
$14.1B
$2.77M 2.34%
+30,210
New +$3.05M
T icon
20
AT&T
T
$165B
$2.63M 2.23%
119,634
-2,892
-2% -$79K
URI icon
21
United Rentals
URI
$71.1B
$2.48M 2.1%
24,101
-575
-2% -$76.2K
EMR icon
22
Emerson Electric
EMR
$82.9B
$2.07M 1.75%
43,490
+295
+0.7% +$19.4K
DE icon
23
Deere & Co
DE
$170B
$1.99M 1.69%
14,430
+264
+2% +$41.8K
LYB icon
24
LyondellBasell Industries
LYB
$19.5B
$1.86M 1.57%
37,490
+1,750
+5% +$129K
V icon
25
Visa
V
$677B
$1.73M 1.47%
10,756
-255
-2% -$48K

Similar funds

Lipe & Dalton's Q1 2020 Portfolio in Review

As of Q1 2020, Lipe & Dalton held 108 positions worth $118M, down 22% from $151M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Lipe & Dalton's Q1 2020 filing shows 3 new, 17 increased, 43 reduced and 11 closed positions. Its largest new stake was Leidos: 30,210 shares worth $2.77M. The largest sale was Hershey, an estimated $1.98M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 22% a quarter earlier, followed by Technology and Financials.

  • Lipe & Dalton's largest Q1 2020 buy was Leidos: 30,210 shares worth $2.77M.
  • Lipe & Dalton added most to McKesson in Q1 2020, an estimated $2.65M increase.
  • Lipe & Dalton's biggest Q1 2020 reduction was Hershey, cutting an estimated $1.98M.
  • Lipe & Dalton fully exited Lear in Q1 2020, selling an estimated $659K.
  • Lipe & Dalton's ten largest holdings make up 38% of its $118M portfolio in Q1 2020.
  • Lipe & Dalton opened 3 new positions and closed 11 in Q1 2020.
  • Lipe & Dalton's portfolio value fell 22% quarter-over-quarter to $118M.

Based on Lipe & Dalton's 13F filing for Q1 2020, filed 1 May 2020.